AMY EASLEY: Open Payments
NPI 1720485600 · MADISON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$808 in 33 payments from 9 companies in 2025. Trend: 2023 $1,818 · 2024 $1,381 · 2025 $808
Food & beverage: $808
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 10 | $250 |
| Vanda Pharmaceuticals Inc. | 3 | $152 |
| Axsome Therapeutics, Inc. | 4 | $90 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| ABBVIE INC. | 4 | $67 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
| Alkermes, Inc. | 2 | $44 |
| Tris Pharma Inc | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
Products named: SPRAVATO, FANAPT, REXULTI, VRAYLAR, Auvelity, COBENFY, ARISTADA, Dyanavel XR.
Industry payments across MS — which companies pay providers there.
